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Until recently, the idea of observing life deep within the tissues of a living mouse, at a resolution
sufficient to pick out cellular behaviors and molecular signals underlying them, remained a
much-coveted dream. Now, a new era of intravital fluorescence microscopy has dawned. In this
Primer, we review the technologies that made this revolution possible and demonstrate how
intravital imaging is beginning to provide quantitative and dynamic insights into cell biology,
immunology, tumor biology, and neurobiology.In the last two decades, there have been enormous advances in
our understanding of mammalian cell biology. A variety of in vitro
and ex vivo methods have been used to decipher signaling path-
ways, identify and exploit biological processes, and validate new
drug targets. However, much of our knowledge derived from
these studies is static and thus does not necessarily reflect the
natural dynamics of biological processes. As such, many
outstanding questions remain: How do cells behave in resting
tissue, interact with one another, and exchange information?
How do cells respond to pathological stimuli and mediate func-
tions? How do specific microenvironments or combinations of
factors control cell fate? And how do cells respond individually
and collectively to therapeutic intervention?
Imaging of live animals at microscopic resolution (intravital
microscopy, IVM) represents a powerful tool for addressing
such questions. IVM can reveal cellular responses over time
and space and can be conducted under conditions closely
approximating those of a natural environment. This is crucial
because cellular behavior is influenced by many factors
including cytokine gradients, interactions with other cellular
and extracellular components, anatomical compartmentaliza-
tion, and forces of fluid flow. As such, cellular behavior can be
very different in in vitro compared to in vivo settings.
In the past, IVM primarily involved bright-field transillumination
of relatively transluscent tissues. Even centuries ago, a rudimen-
tary form of IVM revealed that blood flow within tissues occurs
via microvessels (Hoole, 1800) and that circulating leukocytes
can actively extravasate into inflamed tissue (Dutrochet, 1824;
Wagner, 1839). Today, however, IVM is largely based on the
detection of fluorescence and is primarily used to study the loca-
tion, motility, adhesion, and interactions of individual cells in
three physical dimensions over time. Progress in fluorescence
labeling and detection has also opened up the field to in vivo
imaging in a larger number of channels, at greater depths, for
more extended periods of time, over larger tissue areas, and at
vastly improved subcellular resolutions. These advances have
enabled us to address some longstanding questions in cell
biology. For example, recent IVM discoveries have started to
elucidate how the body initiates and orchestrates innate and
adaptive immune responses; how tumors control angiogenesis,invade tissues, and metastasize; and how cells in the central
nervous system are interconnected and respond to local
damage.
In this Primer, we explain how a convergence of technologies
has not only made high-resolution IVM possible but is now
putting it within the reach of increasing numbers of researchers.
With this in mind, we also provide a guide for those who are inter-
ested in adding IVM to their technology toolbox (see Supple-
mental Information available online). We present a selection of
recent advances that were obtained by IVM and highlight the
current state of the art. Finally, we discuss the technical chal-
lenges and limitations that hold back current research and reveal
the newly emerging technologies that may soon overcome them.
The approaches presented here are intended to complement
other technological advances at the single-molecule (Huang
et al., 2010; Li and Xie, 2011) and macroscopic (Weissleder
and Pittet, 2008; Ntziachristos, 2010) levels, as well as imaging
of nonmammalian systems (Megason and Fraser, 2007). In addi-
tion to enabling the inner workings of mammalian cells to be
interrogated, intravital observations will ultimately impact patient
care, for example by identifying and validating new drug targets
and elucidating how drugs work (or why they fail). Other
emerging clinical applications such as laser endomicroscopy
and surgical imaging are poised to enable real-time microscopic
imaging and in vivo diagnosis (Paramsothy and Leong, 2010).
State-of-the-Heart Technology for Mouse Imaging
The major challenges of IVM are to excite fluorescence in the
tissue of interest, collect the relatively low levels of in-focus light
emitted from it, and separate this signal from the potentially over-
whelming noise of out-of-focus light from the overlying tissue.
This needs to be done with minimal damage to the tissue or
the fluorophore, and with a spatial and temporal resolution suffi-
cient to observe the behavior of individual cells. Excitation is
made possible with scanning lasers that can be focused to excite
fluorescence in a diffraction-limited focal volume. Although
conventional confocal microsopy has the advantages of being
relatively cheap and simple, its use in IVM is restricted by limited
tissue penetration. The development of multiphoton microscopy
has made fluorescent IVM at greater depths possible by takingCell 147, November 23, 2011 ª2011 Elsevier Inc. 983
advantage of the principle that a fluorophore is excited when it
simultaneously absorbs two low-energy photons. In contrast to
confocal microscopy, this allows the laser to selectively excite
fluorescence in a specific focal plane where the two photons
coincide, allowing less photobleaching, lower phototoxicity,
and a reduced autofluorescence signal. Multiphoton imaging
systems can also detect second harmonic signals, which are
signals generated when two photons of one wavelength are
absorbed and replaced by a single photon of half the wave-
length. This process does not require exogenous labeling and
is primarily used to visualize collagen networks.
A variety of other microscope technologies can be used to
expand the range of applications of IVM. For example, ‘‘broad-
band multiphoton imaging’’ allows detection of a larger palette
of fluorescent probes, including those that emit in the far-red
region of the light spectrum (Andresen et al., 2009; Condeelis
and Weissleder, 2010). The more widely tuned lasers required
for broadband imaging not only enable detection of red-shifted
probes but also further increase imaging depth and can reduce
photobleaching and phototoxicity. IVM can also be used to
create an in vivo flow cytometer that can detect cells circulating
at very high speeds. These systems involve a laser light that has
been shaped into a slit across a selected vein or artery and a pho-
tomultiplier tube that samples at a sufficiently high rate as to
detect fast-flowing cells (Boutrus et al., 2007). Optical frequency
domain imaging (OFDI) is another emerging technique for
studying tissues continuously over time and at deeper depths
(up to several millimeters into a tissue) (Vakoc et al., 2009).
OFDI capitalizes on an intrinsic mechanism of contrast based
on reflectivity and can be used to acquire quantitative measure-
ments of angiogenesis, lymphangiogenesis, and tissue viability.
Finally, coherent anti-Stokes Raman scattering (CARS) micros-
copy allows the study of lipid distribution within a tissue (Evans
et al., 2005). Both CARS and OFDI circumvent the use of exog-
enous probes.
However, IVM isn’t just about the microscope: equally impor-
tant has been the development of suitable mouse models in
which biological questions can be answered within a setting
that is not only physiologically relevant but also accessible to
the available technology. For example, the dorsal skin window
chamber model, developed over 70 years ago, remains a widely
used technique in cancer research (Brown et al., 2001).Micewith
implanted window chambers can be maintained for several
weeks, allowing imaging over extended periods. To image the
brain, either thinning of the skull with a drill under a dissecting
microscope (Grutzendler et al., 2002) or the execution of small
craniotomy (Davalos et al., 2005) is necessary. For imaging
deeper within tissues, optical fibers can be implanted after crani-
otomy (Barretto et al., 2011). The skull itself provides another
useful system for visualizing the dynamics of hematopoietic
stem cells: the skull bone marrow model (Mazo et al., 1998)
exploits the delicate nature of the frontoparietal skull bone of
the mouse, which is <100 mm thick and thus sufficiently trans-
parent for multiphoton penetration (Lo Celso et al., 2011). Other
organs can be made more accessible though surgical proce-
dures with variable degrees of invasiveness. The popliteal lymph
nodes can be visualized through a small skin incision (Mempel
et al., 2004), whereas the liver is exteriorized and superfused984 Cell 147, November 23, 2011 ª2011 Elsevier Inc.with physiological saline solution before imaging (Egen et al.,
2011; Wong et al., 2011). Models for other organs, such as the
kidney, pancreas, spleen, and heart, are less well developed
and at a greater risk of artifacts such as inflammatory reactions.
In every model system, muscle contractions, respiration, and
blood vessel pulses can cause movements that need to be
restrained through a combination of deep anesthesia and
some form of physical immobilization.
The third technology that has massively enhanced the power
of IVM is the development of new fluorescent probes. With
a few exceptions (listed above), the vast majority of IVM studies
use fluorescent proteins (FPs) and/or exogenous fluorochromes
to generate image contrast. A large number of genetically
encoded fluorescent probes (such as cleavable or photoactivat-
able/switchable proteins) are now available. Although IVM
demands reporters that can achieve very high signal-to-noise
ratios, minimizing the time required to expose the animal to the
laser while collecting sufficient light to construct a high-resolu-
tion image, enhanced probes have been developed with this
need in mind. Fluorescent dyes are also particularly important
for IVM. Some of these agents are used to stain cells ex vivo
before adoptive transfer (e.g., CMTMR, red; CFSE, green; and
Hoechst 33342, blue), whereas other fluorescent probes can
be injected directly into the animal and enable visualization of
endogenous structures (e.g., blood vessels and lymph via
Angiosense, fluorescent dextrans, and quantum dots), cell
populations (e.g., monocytes and macrophages via iron oxide
nanoparticles), and enzymatic activities (e.g., cathepsins via
Prosense and metalloproteinases via MMPsense) (Michalet
et al., 2005; Weissleder and Pittet, 2008). Increasingly, reactive
fluorochromes and quantum dots are being employed to label
antibodies and other proteins. Newer fluorochromes (Budin
et al., 2011; Reiner et al., 2010) are now available, with increased
cell permeability, biocompatibility, and optimized pharmacoki-
netics for efficient in vivo use.
Current Applications of Intravital Microscopy
How have these converging technologies been applied to key
questions in biology? In this section, we focus primarily on the
cell’s cardinal attributes: division, death, migration, communica-
tion, and fate. Although the examples presented are mainly
derived from studies of cancer and immunology, the same tech-
niques can be applied to other disciplines. Indeed, IVM has been
used in many areas of research including neural, stem cell,
developmental, reproductive, ocular, cutaneous, cardiovas-
cular, and infectious disease biology (additional information on
the use of IVM across disciplines is available in the Supplemental
Information). In particular, neurobiology has the earliest reported
multiphoton IVM studies and continues to actively employ IVM to
study the etiology and therapeutics of neurological diseases.
With further technological developments, it is likely that the use
of IVM will extend to many other disciplines.
Cell Division
A fundamental feature of cancer cells is their ability to sustain
proliferative growth. Original IVM studies of tumor cell prolifera-
tion were limited to the detection of cell division of a single parent
cell into two (or more) daughter cells. However, with the advent
of higher-resolution imaging and the capacity for fluorescently
Figure 1. Imaging Cell Biology In Vivo with IVM
Cell division. Top: Time-lapse IVM of HeLa H2b–mCherry/tubulin–enhanced
green fluorescent protein (EGFP) cells reveals stages of mitosis in vivo. Bottom
left: A higher-magnification image reveals kinetochore fibers in a normal
mitotic cell and microtubule rosettes surrounded by chromosomes in a taxol-
arrested mitotic cell. Bottom right: Quantification of mitotic indexes in
response to anticancer drugs. Images reproduced from Orth et al. (2011).labeling multiple intracellular components, mitosis can now be
studied inmore detail (Figure 1). For example, tumor cells labeled
with specific tags for histone H2b and a-tubulin can be used to
follow nuclear morphology in vivo (Orth et al., 2011). From these
studies, it was clear that cell division proceeds at a similar speed
and sequence in vivo as it does in vitro; however, the initiation of
mitosis in vivo was found to be a far less frequent event than it
was in vitro. Other IVM reporters currently in use include FUCCI
(APC.Cdh1 [G1]; Scf.Skp2 [S,G2]) (Sakaue-Sawano et al., 2008)
and Ki67-XFP. These tools are now available for investigating
questions such as, how is tumor cell proliferation controlled by
stromal interactions and by exposure to vasculature? Does cell
division contribute to other processes such as invasion? What
effects do drugs have in vivo? Can quantitative and predictive
models of cell amplification be developed (see below)?
Cell Death
A variety of apoptosis readouts have become available or are
under investigation for in vivo imaging (Figure 1). One in vivo
readout of cell death consists of administering mice with target
cells previously labeled with both a cytoplasmic and a nucleic
dye (Mempel et al., 2006); this approach has been used to define
the outcome of physical interactions between surrogate tumor
cells and cytotoxic T lymphocytes. Because a lethal hit by the
lymphocyte leads to a measurable change in the cytoplasmic-
to-nucleic fluorescent ratio of the target cell, time-lapse IVM
allows the status (dead or alive) of target cells to be tracked
over time. However, this approach limits detection of cell death
following fresh cell injection. Other readouts make use of Foer-
ster resonance energy transfer (FRET) reporters of caspase
activity (CFP-DEVD-YFP) (Breart et al., 2008), mitochrondrial
membrane-fusion proteins (IMS-XFP) that change shape during
mitochondrial outer membrane permeabilization (MOMP)
(Albeck et al., 2008), Bcl2-XFP fusion proteins (Wang et al.,
2001), or turn-on XFP reporters (Nicholls et al., 2011). Nuclear
morphology can also be assessed using H2B-XFP (Orth et al.,
2011). Changes in nuclear morphology detected by H2B-XFP
(in combination with a-tubulin-XFP) during cell death include
multinucleation, cell-cycle arrest, or abnormal (bipolar, multi-
polar) mitosis. Other cell viability IVM readouts include the
measurement of p53 DNA-damage reporters (P53BP1-XFP)
(Giesen et al., 2011) or the use of LC3-XFP mice (Tian et al.,
2010) to track autophagy. Drug-induced cell death andCell death. Top: Cell death reporters. From left to right: H2b-XFP (nuclear
morphology) (Orth et al., 2011); IMS-XFP (mitochondrial outer membrane
permeabilization); Bcl2-XFP (apoptosis signaling); and LC3-XFP (autophago-
somes). Bottom left: Target cell (red cytoplasmic marker, blue nucleus) killing
by a cytotoxic T lymphocyte (green). Loss of cell membrane integrity results in
a decreased red/blue ratio. Images reproduced from Mempel et al. (2006).
Bottom right: Cytotoxic T lymphocyte-mediated tumor cell apoptosis detected
using a FRET-based reporter of caspase 3 activity. Live tumor cell: orange;
apoptotic tumor cell: green; cytotoxic T lymphocyte: red. Images reproduced
from Breart et al. (2008).
Cell migration. Left: Single-cell tracks (top) and quantification of cell dis-
placement (bottom) of reservoir splenic monocytes in response to a distant
injury. Right: Extravasation of a splenic monocyte for redistribution to distant
tissues. Images reproduced from Swirski et al. (2009).
Cell communication. Top: Rare long-lasting physical interactions between two
immune cell types (images reproduced from Mempel et al., 2006). Bottom: A
lymph node dendritic cell interacting with five different lymphocytes, with
quantification of interaction times between different cell types.
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mechanisms of apoptosis regulation in vivo (Spencer et al., 2009;
Spencer and Sorger, 2011) are other fields in which IVM research
is emerging.
Cell Migration
Extensive in vitro work has already defined how the anchoring of
a cell membrane to extracellular substrates allows intracellularly
generated forces to be translated into cell locomotion. Now, with
the use of multiphoton IVM, cell migration can be studied directly
in vivo (Figure 1). With this system, infrared excitation enables
deeper imaging into tissues, whereas laser scanheads allow
stacks of two-dimensional optical tissue sections to be obtained;
these sections can then be digitally assembled into three-dimen-
sional datasets. Repeated imaging at defined intervals thus
enables cells’ migratory path, velocity, motility, chemotactic
index, and physical interactions with other tissue components
to be determined (Sumen et al., 2004). Using this generic
approach, migration of multiple cell types can be studied,
including cancer cells, stem cells, as well as various immune
cell populations. One issue that has received particular attention
is whether cell migration in tissue is random or directional
(reviewed in Pittet andMempel, 2008). In answer to this question,
a recent IVM study provided evidence to suggest that cell migra-
tion through tissue relies on the sole force of actin-network
expansion (La¨mmermann et al., 2008). Thus, in contrast to earlier
in vitro findings, migration in vivo can occur in the absence of
specific adhesive interactions with the extracellular environment.
Other studies have indicated that the motility of naive T lympho-
cytes in lymph nodes depends on chemokine receptor-ligand
interactions (Okada and Cyster, 2007; Worbs et al., 2007),
even though the directionality of migration seems not to be influ-
enced by chemokine gradients (Miller et al., 2003). Chemokines
do however direct the migration of leukocytes in certain situa-
tions. For example, chemotaxis has been shown in lymph node
B cells that, following antigen priming and functional reprogram-
ming, migrate along a CCR7 ligand gradient toward the T cell
zone; this process results in initiation of T cell-dependent
humoral immune responses (Okada et al., 2005).
IVM studies of cancer and morphogenesis have likewise
demonstrated that cells can sometimes migrate as a cohesive
group. This process, known as ‘‘collective cell migration,’’
involves the movement of cells that are physically connected
via cell-cell junctions. Within this group, the leader cell may facil-
itatemigration not only by participating in chemotaxis but also by
exhibiting proteolytic activity. Attached cells are thus dragged
along a remodeledmatrix track (Alexander et al., 2008; Giampieri
et al., 2009). IVM can also be used to investigate cell mobilization
from one tissue to another. For example, IVM has recently been
used to study the mobilization of both adaptive (Mrass et al.,
2006; Boissonnas et al., 2007) and innate (Auffray et al., 2007;
McDonald et al., 2010; Swirski et al., 2009) immune cells to sites
of inflammation.
Cell Communication
Cells communicate constantly with their environment either by
releasing and sensing soluble factors or by initiating physical
interactions. These processes are of significant importance as
they have the power to influence key cell parameters such as
proliferation, survival, and motility, as well as regulate effector
functions. However, cell communication and its functional986 Cell 147, November 23, 2011 ª2011 Elsevier Inc.consequences remain difficult to probe in vivo (seeCurrent Limi-
tations and Emerging Technologies below). At present, IVM
studies are typically limited to the tracking of whole cells (rather
than their molecular activities) and thus need to be comple-
mented using ex vivo approaches. Existing IVM approaches
have nevertheless already elucidated many important facets of
cell-cell interactions through the systematic comparison of two
or more experimental conditions (e.g., wild-type versus
knockout animals, or animals with/without defined cell popula-
tions).
A considerable body of knowledge regarding microenviron-
mental cellular networks has accumulated from immunology
studies (Figure 1). For example, unlike previous in vitro findings,
IVM investigations of lymphocyte activation have revealed that
naive T cells in lymph nodes of anesthetized mice continuously
migrate and scan antigen-presenting dendritic cell populations
(Miller et al., 2003; Mempel et al., 2004). These (and other) results
have helped to explain how lymphocytes optimize their chances
of encountering rare cognate antigens and initiate adaptive
immune responses (Bousso, 2008). IVM studies have likewise
been used to demonstrate the complexity of cellular communi-
cation in vivo by showing the presence of ‘‘me´nage a` trois’’ inter-
actions that either boost or suppress adaptive immune
responses. For example, productive interactions between
dendritic cells and CD4 helper T cells result in the release of che-
mokine signals that attract CCR5+ CD8 T cells and enhance the
scanning of well-stimulated dendritic cells by CD8 T cells (Cas-
tellino et al., 2006; Hickman et al., 2011). In contrast, effective
interactions between dendritic cells and CD4 regulatory T cells
inhibit CD4 helper T cell activities (Tang et al., 2006).
IVM has also been used as a tool for characterizing the inva-
sive tumor microenvironment. For example, in breast cancer
models, perivascular macrophages have been shown to directly
communicate with cancer cells and to facilitate their migration
and intravasation (Wyckoff et al., 2004). Second, harmonic
imaging has further revealed that the migration of tumor cells
and macrophages occurs along collagen fibers, a finding which
has served to confirm that components of the extracellular
matrix are important to the invasive microenvironment (Roussos
et al., 2011). IVM studies using a model of brain metastasis have
indicated that premetastatic circulating tumor cells often arrest
at vascular branch points and extravasate through small holes
in the vascular wall, where they typically remain within the close
vicinity of microvessels. Here, tumor cells act to induce perivas-
cular growth either by vessel co-option or by angiogenesis (Kie-
nast et al., 2010). Another study has likewise revealed a key role
of macrophages during the metastatic process (Qian et al.,
2009). By tracking several cell populations simultaneously, IVM
technologies have allowed us to advance our overall under-
standing of the tumormicroenvironment. It is likely that IVM tech-
nologies will also be invaluable in determining how host cell
networks respond to anticancer drugs, which in turn may
advance current therapeutic options.
There is an ongoing effort toward developing technologies that
will extend our ability to study cell communication, such that
specific outcomes following cellular interactions are detectable
at the molecular level. For example, cellular calcium fluxes can
be monitored in vivo and have been used as a measure of
Figure 2. Mapping of Long-Term Cell Fate
by IVM
(A) Green to red photoswitching of Dendra2-
expressing tumor cells in avascular (left) and
vascular (right) regions in vivo. White dotted lines
delineate the position of the vessel. Photo-
switched cells can be tracked for up to 5 days and
show distinct behaviors depending on their orig-
inal position. Images reproduced from Kedrin et al.
(2008).
(B) Orange to far-red photoswitching of PSmOr-
ange in HeLa cells. Micrographs show PSmOr-
ange-tubulin coexpressed with NLS-mCherry.
Images reproduced from Subach et al. (2011).
(C) The Brainbow transgenic technique for
combinatorial expression of fluorescent proteins.
The image, reproduced from Livet et al. (2007), is
of individual neurons in the hippocampus, where
neurons express either CFP, YFP, or RFP trans-
genes. Coexpression of multiple copies of fluo-
rescent reporters can generate up to 90 colors.
(D) RGB marking with LeGO vectors encoding
mCherry (red), Venus (yellow-green), and Cerulean
(blue) fluorescent proteins represents another
recombination strategy that can be used for
mapping cell fate. Simultaneous expression of
these fluorescent proteins creates a spectrum of
colors that can be then used to identify single
clones. Images reproduced from Weber et al.
(2011).membrane depolarization during neuronal activity (Svoboda
et al., 1997). Calcium fluxes have also been used as an indicator
of antigen stimulation following the engagement of B cells with
dendritic cells in lymph nodes (Qi et al., 2006). Furthermore,
a transgenic mouse expressing a T cell receptor (TCR)-GFP
fusion protein has recently been developed to enable the visual-
ization of TCR clustering and internalization following their
encounter with antigen on dendritic cells (Friedman et al.,
2010). Other technologies for molecular imaging at subcellular
resolution will likely emerge within the next decade.
Cell Fate
IVM is a useful tool for tracking the behavior of individual cells
over relatively short timeframes (several hours) and within a rela-
tively confined environment (<0.1 mm3). In general, however,
IVM does not allow the same cells to be tracked for longer
periods (days to weeks) or in areas away from the region origi-
nally imaged. Fortunately, these limitations may soon be over-
come by new emerging methods.
One approach involves selectively tagging a small fraction
(e.g., 1 to 100 cells) of cells of interest directly in vivo and then
following the fate of these cells at a particular time and place (Fig-
ure 2A). Such selective in vivo tagging can be achieved using
cells that code for a photoswitchable protein, such as Dendra2.
Prior to photoswitching, Dendra2 resembles GFP in its spec-
trum, but on exposure to light (e.g., 405 nm), an irreversible red
shift of >150 nm in the excitation and emission spectra of the
fluorophore occurs. Following the photoswitch, the red fluores-
cence increases by 250-fold, which allows the selected cells
to be distinguished for at least 5 days (after which, cell prolifera-
tion and protein turnover eventually dilute the photoswitched
protein). This photoswitching approach has already beensuccessfully employed for studying primary cancer cell coloniza-
tion at distant organs in an orthotopic mammary mouse cancer
model. Findings from this study revealed that distinct tumor mi-
croenvironments exhibit different rates of tumor cell invasion
and intravasation where, for instance, the tumor perivascular
environment selectively promotes tumor metastatic behavior
(Kedrin et al., 2008). This approach has also enabled detection
of photoswitched cells that have migrated to metastatic sites.
PSmOrange (Figure 2B) is another example of a photoswitchable
protein, in which irradiation causes a color change from orange
to far-red (Subach et al., 2011). The existence of such photo-
switchable proteins with distinct optical properties now opens
up avenues for tracking the fates of several cell populations
simultaneously.
Another significant advancement has been the introduction of
genetic constructs for labeling clonal cell populations with
distinct colors. The initial technology, known as Brainbow (Livet
et al., 2007), used a Cre/lox recombination system that stochas-
tically defines the expression of multiple copies of constructs
coding for diverse fluorescent proteins (Figure 2C). The process
creates a mosaic of up to 90 distinguishable colors, which can
then be stably defined. This system has already been used to
label and detect individual adjacent neurons, their connectivity,
as well as the fate and interactions of cells over time in vivo. In
principle, the Brainbow cassettes are adaptable to any cell
type sensitive to site-specific recombinases. An alternative
recombination strategy, known as RGB marking, uses lentiviral
gene ontology (LeGO) vectors encoding red, green, and blue
fluorescent proteins (Weber et al., 2011). In this system, RGB-
coded cell populations can be tracked by IVM following adoptive
transfer (Figure 2D). Both the Brainbow and LeGO technologiesCell 147, November 23, 2011 ª2011 Elsevier Inc. 987
appear well suited to following clonal histories of cell populations
and will thus likely be useful for addressing biological questions
from a variety of disciplines.
Fluorescent reporter assays have also been developed to
detect gene activation (or inactivation) based on the expression
of certain fluorescent proteins. For example, a bicistronic fluo-
rescent reporter that allows visualization of interferon-gamma
gene activation has been used to observe early diversification
of T lymphocyte responses following antigen priming in lymph
nodes (Beuneu et al., 2010).
The above-described in vivo readouts will likely complement
genetic approaches that use unique molecular identifiers, e.g.,
to follow hematopoietic stem cells and their progeny (Lu et al.,
2011) or to track primary tumors and their related metastases
(Winslow et al., 2011). In the latter cancer study, specific alter-
ations in gene expression were identified that could distinguish
metastatic from nonmetastatic tumors. It would be interesting
to now investigate such differences further via IVM.
Vascular Networks
Tumor progression andmetastases are dependent on the forma-
tion of new blood vessels; these support the tumor’s nutrient and
oxygen needs, allow delivery of tumor-supporting host cells, and
enable tumor cells to be disseminated to distant organs.With the
advent of multiphoton microscopy, it has become possible to
perform time-lapse studies in three dimensions of relatively
deep-seated (up to 300 mm) tumor tissue (Brown et al., 2003).
This has enabledmeasurement of hemodynamics, vessel perme-
ability, and drug delivery to tumors, as well as of vascular re-
sponses to therapy. Blood vessels are typically visualized
following the intravenous injectionof fluorescent agentswith rela-
tively long blood half-lives. The additional visualization of endo-
thelial cells involves the use of transgenic animal models (e.g.,
TIE2-XFP) or in vivo labelingwithfluorescent lectinsor antibodies.
It is likely that future IVM studies will not only enhance our mech-
anistic understanding of vascular networks but also enable iden-
tification of optimal treatment regimens (dosage, duration, novel
antiangiogenic drug combinations), which eliminate and/or nor-
malize tumor blood vessels in patients (Carmeliet and Jain,
2011). Having the ability to study dynamic changes over larger
areas and over prolonged periods will also enable us to observe
the unfolding of drug responses within the heterogeneous tumor
environment. OFDI is one example of a new IVM technology that
could be useful for such studies because it allows tissue vessels
to be observed at greater depths (Vakoc et al., 2009).
Current Limitations and Emerging Concepts
The maturity of today’s IVM technology enables us to revisit
long-standing biological paradigms––and address new ones––
by submitting specific hypotheses to direct in situ observation,
across a variety of research disciplines. However, a sus-
tained effort is required if we are to fully realize the promise of
higher-resolution microscopy for the study of in vivo biology,
pathophysiology, and pharmacology. Although experimental
challenges still exist, they also provide a community-wide oppor-
tunity for the development of new tools and approaches.
Better Assessment of Biological Complexity
The IVM studies highlighted in this Primer are intended to
demonstrate the exceptional capacity and ongoing potential of988 Cell 147, November 23, 2011 ª2011 Elsevier Inc.new imaging techniques for studying cell biology directly in vivo.
The readouts currently used, however, are not always capable of
capturing the full complexity of biological events. Indeed, to
date, most of the components within a tissue analyzed by IVM
continue to remain ‘‘unseen.’’ Thus, having the ability to examine
a wider range of relevant parameters will no doubt enhance our
understanding of how tissues are organized and how single cells
receive and provide information. Although the factors requiring
simultaneous assessment may be different for each investiga-
tion, they will likely involve a combination of cell types (stromal
cells, immune cells, others), structural components (extracellular
matrix, vessels, nerves), and chemical mediators (cytokines,
lipids, enzymes). Below we discuss how this goal might be
achieved.
First, new mouse genetic models are required to enable
greater numbers of endogenous constituents to be studied
simultaneously. These are dependent on the use of genetic fluo-
rescent reporters that can be spectrally resolved (Shaner et al.,
2005). Although the concomitant incorporation of several
imaging constructs into transgenic mice is relatively time-
consuming, it will likely be of huge value. In particular, we expect
that future IVM cancer studies will employ pre-existing mouse
conditional genetic tumormodels (DuPage et al., 2009). Because
cancers in these mice closely recapitulate the human disease,
the addition of imaging reporters will allow the disease to be
investigated more closely than is currently possible using tumor
cell lines. The detection of fluorescence across a wider range of
wavelengths and the implementation of additional imaging chan-
nels for detection of multiple biosensors are other possible
options.
Second, new technologies are needed for refining our analysis
of the cell’s major molecular pathways, biological processes,
and drug targets. This could be achieved by developing cell lines
and mouse models with relevant fluorescent reporters (e.g.,
fusion proteins [Friedman et al., 2010] or FRET sensors [Breart
et al., 2008]) or with cell-permeable and fluorescent drugs that
have molecular specificity (Budin et al., 2011; Reiner et al.,
2011). Although injectable probes hold the potential for transla-
tion into human use, their validation will require careful in vivo
testing (Weissleder and Pittet, 2008). Our capacity to visualize
molecular activities by IVM will also require validation of the
sensitive microscope hardware, which is capable of detecting
fluorescent reporters expressed at physiological levels. It is
possible that quantum dots with long excitation lifetimes will
be useful for attaining this goal.
Other variables will likewise require in vivo scrutiny. For
example, current IVM technologies do not permit dynamic
high-resolution imaging of all tissues, and of the tissues that
can be imaged, it is not always possible to do so deeply.
Improvements to current technology could be achieved through
the development of engineering methods that reduce physio-
logic motion, allow deeper photon penetration, and/or enable
closer access to the tissue (for example, via stick objectives or
microendoscopes). Promising efforts to improve penetration
depth include the use of far-red probes and longer wavelength
lasers (Andresen et al., 2009; Condeelis and Weissleder, 2010)
and/or adaptive optics (Rueckel et al., 2006). Current IVM
methods are also not generally able to image large areas of
Figure 3. IVM for Assessing Drug Distribution In Vivo at the Single-
Cell Level
(A) Bioorthogonal chemistry allows a fluorochrome to be irreversibly ‘‘clicked’’
onto drugs. Here, the poly-ADP-ribose-polymerase (PARP)-1 inhibitor
AZD2281 was modified to incorporate the permeable fluorochrome BODIPY.
(B) In vivo distribution of the fluorescent PARP-1 inhibitor (red) 90 min after its
intravenous injection into fibrosarcoma-bearing mice; tumor cells are
expressing fluorescent H2b (green). IVM could identify drug distribution in
most tumor cells (white arrows), where the drug is most likely accumulating
within the nucleoli. Within the same microenvironment, the drug also accu-
mulates in high concentrations in nontumor cells (red arrows).tissues. Methods that can integrate meso- and microscopic
information would thus be useful for resolving the heterogeneity
of tissue components at a larger scale. Moreover, the speed at
which optical tissue sections are presently scanned not only
limits the time resolution in volume imaging but typically allows
only relatively slow dynamic processes to be observed. Methods
that increase image collection rates should facilitate the tracking
of fast-moving objects in less restricted tissue volumes. Finally,
the ability to track single cells over prolonged periods (weeks
or months) is currently limited. The above-mentioned Brainbow
and LeGO approaches offer potentially valuable options for
overcoming this limitation.
Analysis of Drug Responses at the Single-Cell Level
Systems biologists, primarily in academia, are currently
modeling molecular pathways at a cellular level to predict the
effects of perturbation. In parallel, pharmacologists, many in
industry, are working toward advancing models of disease,
pharmacokinetics, and pharmacodynamics; these typically
involve coarse grained multicompartment models correspond-
ing to blood, cancer, and major organs. IVM is now emerging
as an important tool for connecting these levels of analysis,
enabling more reliable pharmacokinetics/pharmacodynamics
information and thus a better understanding of the action
and failure of drugs.
In a recent study, high-resolution IVM was used to assess the
effects of the mitotic inhibitor Paclitaxel on tumor cells in vivo.
Observations included defective spindle assembly, subsequent
mitotic arrest, slippage, multinucleation, and apoptosis, all of
which were readily detectable in individual cancer cells (Orth
et al., 2011). The morphologies of mitotic defects induced by
the drug were both dose and time dependent and could there-
fore be used to determine semiquantitative, single-cell
measures of pharmacodynamics. In response to Paclitaxel,
tumor cells in mice showed a much lower peak mitotic index
than those in cell culture. Indeed, surprisingly, many tumor cells
did not progress past mitotic arrest, even in conditions where
the drug triggered significant tumor regression. Furthermore,
unlike in culture where tumor cells underwent apoptosis, tumor
cells in the mice survived longer after mitotic arrest and became
multinucleated rather than dying; this suggests that the environ-
ment in vivo can be much less proapoptotic and that our under-
standing of the real impact of drugs in vivo remains relatively
limited.
Future studies designed to address the above issues will likely
make use of emerging bioorthogonal chemistries, which can flu-
orescently ‘‘tag’’ drug analogs (Figure 3), and thus enable
measurements of pharmocokinetics by IVM (Reiner et al.,
2010; Budin et al., 2011). Using such chemistries, it is now
possible to assess in vivo drug distribution across a variety of
cellular (including intracellular) compartments. Major goals will
be to both define the final destination of specific drugs (e.g., in
tumor cells or in non-neoplastic tumor-associated stromal
components) and determine the effects of drugs on heteroge-
neous cell populations and distinct microenvironments. New
mathematical models of drug distribution and response will
also be of value. Such models could be used to fill in ‘‘missing
data’’ from intravital time series, provide insights into dose-
response relationships at the single-cell level in whole tissues,and then link information on drug exposure to molecular models
of drug response pathways.
Data Extraction, Automation, Modeling, Integration, and
Visualization
Currently available computing tools allow information from IVM
datasets to be extracted and quantified. However, there is still
a need for improved data standards, better techniques for seg-
menting images and quantifying information, new methods for
data incorporation into mathematical models, and more flexible,
reliable, and distributed data management systems. Moreover,
the extraction of quantitative data from intravital image
sequences is often still done manually and can be laborious to
perform. Automated tools are thus needed to enable more
sophisticated segmentation and tracking of cells, both in three
dimensions and in whole tissues. Ultimately having the ability to
manage large datasets ‘‘on the fly,’’ perform complex recon-
structions in real time, andachieveautomatedmicroscopic image
stitchingof three-dimensional tissue areaswouldbe useful. There
is therefore a need for newapproaches that not only integrate and
manipulate multiscale image data but also extract precise
numerical information to allow cellular circuits at different levels
of cellular and molecular detail to be mapped and modeled. It is
likely that the achievement of this goal will require a synthesis of
previous knowledge together with information gained from high-
throughput screens, in vivo imaging, and direct experimental
tests of key hypotheses in relevant in vivo animal models. Such
computational methods could eventually be used to assess
whether the topology or dynamics of pathways in certain cell
phenotypes can predict natural outcomes or drug responses.
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